NCT06142981View on ClinicalTrials.gov

PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

September 15, 2022

Study Completion Date

December 15, 2022

Conditions
Regenerative Medicine
Interventions
BIOLOGICAL

PRP and PBD-VSEL Stem Cell therapy

The intervention began with the administration of three PRP sessions, where the patients received intravenous injections at four acupuncture points (stomach 36 and GB 34 on both sides) at the 1st, 2nd, and 3rd month.

Trial Locations (1)

54780

gull e Rukh, Lahore

All Listed Sponsors
lead

Fatima Jinnah Medical University

OTHER

NCT06142981 - PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease | Biotech Hunter | Biotech Hunter